31
Growth Score in past quarter
pts
Heat Score 31 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Eleventa is a biotechnology company.
About the Company
Eleventa is a Russian biotechnology company founded in 2012 to develop and commercialize innovative products for the treatment of asthma and other allergic and inflammatory respiratory diseases.
Leading drug candidate OС000459 is a small molecule compound active and selective antagonist of CRTH2 receptors that play a key role in initiating
allergic inflammation. The drug has a significant anti-inflammatory effect and is used for the treatment of moderate to severe asthma and other respiratory allergies.
OC000459 developed in partnership with the biotechnology company Oxagen, Ltd. (UK).